Testimony: Restricting Youth Access to Nicotine and Tobacco Products
Delivered to Philadelphia City Council
Population Health
Policy
Comment: Patient Focused Drug Development: Methodologic and Other Challenges Related to Patient Experience Data
Submitted to the Food and Drug Administration and Department of Health and Human Services
Print:
On December 18, 2024, LDI Senior Fellow Sean Hennessy, PharmD, PhD submitted a comment in response to a Request for Comments from the U.S Food and Drug Administration and U.S. Department of Health and Human Services. The request sought input regarding methodological challenges related to data on patient experience.
As an expert in pharmacoepidemiology, the study of the health effects of drugs and other medical products in populations, Dr. Hennessy provides 10 suggestions for improving the use of patient experience data in patient focused drug development.
More on Policy at LDI
Briefing: Nursing Home Staffing Mandate and Resident Outcomes
Presented to Staff of U.S. Senate Committee on Finance
Comment: Studies from Penn LDI on Medicare Post-Acute Care
Submitted to the U.S. Committee on Ways & Means Subcommittee on Health
Comment: Insurance Coverage for Over-the-Counter Preventive Services Without a Prescription
Submitted to the U.S. Departments of Treasury, Labor, and Health and Human Services
Briefing: Medicaid Insurance and Sterilization Access – Opportunity for Change
Presented to Staff from the Office of U.S. Representative Pramila Jayapal
Briefing: The Impact of Repealing the Centers for Medicare and Medicaid Services Minimum Staffing Rule on Patient Outcomes
Presented to U.S. Senator Elizabeth Warren